Connect with us

Hi, what are you looking for?

Jewish Business News


Teva buying back $1Billion of debt

Teva says that the move is designed to reduce its finance costs.


Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) announced today that was making tender offers for its bonds to the tune of $1 billion, with the aim of reducing its finance costs. The company says that the buyback will be financed “through a future offering of Eurobonds or other senior notes, borrowings under its existing credit facilities and/or other available cash.”

Teva is offering early redemption to holders of four of its bond series: 6.150% Senior Notes due 2036 issued by Teva Pharmaceutical Finance Company, LLC; 3.650% Senior Notes due 2021 issued by Teva Pharmaceutical Finance Company B.V. (“Teva BV”) and 3.650% Senior Notes due 2021 issued by Teva Pharmaceutical Finance IV B.V.; 2.950% Senior Notes due 2022 issued by Teva BV; and 2.400% Senior Notes due 2016.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.

Published by Globes [online], Israel business news –



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Copyright © 2021 Jewish Business News